The World Health Organization, on Tuesday, approved China’s Sinovac vaccine for emergency use in the fight against COVID-19.

It’s the second Chinese-developed vaccine that can now be included in COVAX, the global program providing vaccines to developing countries.

Last month, the Chinese vaccine, Sinopharm, received approval. More than 1.9 billion doses of vaccines have been administered globally but many countries are still struggling with enough supply.

Joining the discussion:

• Laura Carlsen is the Director of Americas.org, an independent international relations think tank.
• Nelson Franco Jobim is a journalist and academic lecturer.
• Dr. Rosie Chauhan is a medical analyst and author of the forthcoming book, “Healer.”
• Dr. Lee Riley is a professor and Chair of the Division of Infectious Disease & Vaccinology at the University of California, Berkeley.

For more:

The World Health Organization #WHO on Tuesday listed the COVID-19 vaccine from China’s Sinovac for emergency use. #CGTNAmericahttps://t.co/uTTfs1db6I https://t.co/vYpO095Alg

— CGTN (@CGTNOfficial) June 1, 2021

Brazil to host Copa America as Covid-19 hit Argentina withdraws https://t.co/7o95Cqt0mE

— Business Day (@BDliveSA) May 31, 2021